← Open Payments lookup

EMILY HECKMAN: Open Payments

NPI 1902327927 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,443 in 83 payments from 22 companies in 2025. Trend: 2023 $1,445 · 2024 $1,820 · 2025 $1,443

Food & beverage: $1,443
CompanyPaymentsAmount
ABBVIE INC.33$477
Novo Nordisk Inc11$182
AstraZeneca Pharmaceuticals LP6$147
Abbott Laboratories5$87
Amgen Inc.4$68
Lilly USA, LLC3$61
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$50
Amneal Pharmaceuticals LLC2$39
Kowa Pharmaceuticals America, Inc.2$39
Boehringer Ingelheim Pharmaceuticals, Inc.2$37

Products named: QULIPTA, UBRELVY, VRAYLAR, AIRSUPRA, Rybelsus, OTEZLA, FREESTYLE LIBRE 3, CAPLYTA.

Industry payments across PA — which companies pay providers there.